|
1 Indications & Usage Venlafaxine Hydrochloride Extended-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For The Treatment Of: • Major Depressive Disorder (Mdd) • Generalized Anxiety Disorder (Gad) • Social Anxiety Disorder (Sad) • Panic Disorder (Pd) 1.1 Major Depressive Disorder Venlafaxine Hydrochloride Extended-Release Capsules Are Indicated For The Treatment Of Major Depressive Disorder (Mdd). Efficacy Was Established In Three Short-Term (4, 8, And 12 Weeks) And Two Long-Term, Maintenance Trials. 1.2 Generalized Anxiety Disorder Venlafaxine Hydrochloride Extended-Release Capsules Are Indicated For The Treatment Of Generalized Anxiety Disorder (Gad). Efficacy Was Established In Two 8-Week And Two 26-Week Placebo-Controlled Trials. 1.3 Social Anxiety Disorder Venlafaxine Hydrochloride Extended-Release Capsules Are Indicated For The Treatment Of Social Anxiety Disorder (Sad), Also Known As Social Phobia. Efficacy Was Established In Four 12-Week And One 26-Week, Placebo-Controlled Trials. 1.4 Panic Disorder Venlafaxine Hydrochloride Extended-Release Capsules Are Indicated For The Treatment Of Panic Disorder (Pd), With Or Without Agoraphobia. Efficacy Was Established In Two 12-Week Placebo-Controlled Trials.
|